English   español  

Browsing by Author Ismaili, L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 21  next >
RightsPreviewIssue DateTitleAuthor(s)Type
openAccessASS234 As a New Multi-Target Directed.pdf.jpg28-Jun-2016ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease TherapyMarco-Contelles, José ; Unzeta, Mercedes; Bolea, Irene; Esteban, Gerard; Ramsay, Rona R.; Romero, Alejandro ; Martínez-Murillo, Ricardo ; Carreiras, M. Carmo; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2020Automated Synthesis of New QuinoxalinetacrinesBautista-Aguilera, Óscar M.; Ismaili, L.; Chioua, Mourad  ; Iriepa, Isabel; Martínez-Grau, Angeles; Beadle, C. D.; Vetman, T.; López-Muñoz, Francisco; Marco-Contelles, José artículo
openAccessJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY.pdf.jpg2019Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapyPachón-Angona, I.; Refouvelet, B.; Andrýs, R.; Martin, H.; Luzet, V.; Iriepa, I.; Moraleda, I.; Diez-Iriepa, D.; Oset-Gasque, M. J.; Marco-Contelles, José ; Musilek, K.; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2015Donepezil-ferulic acid hybrids as anti-Alzheimer drugsBenchekroun, M.; Ismaili, L.; Pudlo, M.; Luzet, V.; Gharbi, T.; Refouvelet, B.; Marco-Contelles, José artículo
closedAccessaccesoRestringido.pdf.jpg2017Facile one-pot synthesis of new [1,2,4]triazolo[1,5-a]pyridine derivatives by ultrasonic irradiationZribi, L.; Zribi, F.; Marco-Contelles, José ; Chabchoub, F.; Ismaili, L.artículo
openAccessmolecules-21-00400.pdf.jpg24-Mar-2016Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease TherapyBoulebd, Houssem; Ismaili, L.; Bartolini, Manuela; Bouraiou, Abdelmalek; Andrisano, Vincenza; Martin, Hélène; Bonet, Alexandre; Moraleda, Ignacio; Iriepa, Isabel; Chioua, Mourad  ; Belfaitah, Ali; Marco-Contelles, José artículo
closedAccessaccesoRestringido.pdf.jpg2019Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapyMalek, R.; Maj, M.; Wnorowski, A.; Józwiak, K.; Martin, H.; Iriepa, I.; Moraleda, I.; Chabchoub, F.; Marco-Contelles, José ; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2017Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative DiseasesBautista-Aguilera, Óscar M.; Hagenow, S.; Palomino-Antolin, A.; Farré-Alins, V.; Ismaili, L.; Joffrin, P. L.; Jimeno, M. Luisa; Soukup, O.; Janockova, Jana; Kalinowski, A.; Proschak, E.; Iriepa, Isabel; Moraleda, I.; Schwed, J. S.; Romero Martínez, Alejandro; López-Muñoz, Francisco; Chioua, Mourad  ; Egea, Javier; Ramsay, R. R.; Marco-Contelles, José ; Stark, H.artículo
closedAccessaccesoRestringido.pdf.jpg2017New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer diseaseBoulebd, Houssem; Ismaili, L.; Martin, H.; Bonet, A.; Chioua, Mourad  ; Marco-Contelles, José ; Belfaitah, A.artículo
closedAccessaccesoRestringido.pdf.jpg2019New method for the synthesis of 4-aryl-3,4-dihydro-2H-benzo[g]chromene-2,5,10-trionesChoura, E.; Ncir, M.; Maalej, E.; Marco-Contelles, José ; Ismaili, L.; Chabchoub,Fakherartículo
openAccessaccesoRestringido.pdf.jpg2015Novel tacrine-grafted ugi adducts as multipotent anti-alzheimer drugs: A synthetic renewal in tacrine-ferulic acid hybridsBenchekroun, M.; Bartolini, Manuela; Egea, Javier; Romero, A. ; Soriano, Elena ; Pudlo, M.; Luzet, Vincenza; Andrisano, V.; Jimeno, M. Luisa ; López, M. G.; Wehle, S.; Gharbi, T.; Refouvelet, B.; Andrés, L. de; Herrera-Arozamena, Clara; Monti, B.; Bolognesi, Maria Laura; Rodríguez-Franco, María Isabel ; Decker, M.; Marco-Contelles, José ; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2020Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapydo Carmo Carreiras, María; Ismaili, L.; Marco-Contelles, José artículo
openAccessmolecules-21-00634.pdf.jpg14-May-2016Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s DiseaseDgachi, Youssef; Bautista-Aguilera, Óscar M.; Benchekroun, M.; Martin, Hélène; Bonet, Alexandre; Knez, Damijan; Godyń, Justyna; Malawska, Bárbara; Gobec, Stanislav; Chioua, Mourad  ; Janockova, Jana; Soukup, O.; Chabchoub, Fakher; Marco-Contelles, José ; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2019Synthesis and Biological Evaluation of Novel Chromone+Donepezil Hybrids for Alzheimer's Disease TherapyMalek, R.; Refouvelet, B.; Benchekroun, M.; Iriepa, I.; Moraleda, I.; Andrys, R.; Musilek, K.; Marco-Contelles, José ; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2019Synthesis of (±)-cis-1-Aryl-3-oxo-2,3-dihydro-1H-benzo[f]chromene-2-carbonitriles and (±)-trans-4-Aryl-2-oxo-3,4-dihydro-2H-benzo[h]chromene-3-carbonitrilesMkaouar, K.; Iriepa, I.; Diez-Iriepa, Daniel; Marco-Contelles, José ; Ismaili, L.; Chabchoub, F.artículo
closedAccessaccesoRestringido.pdf.jpg2019Synthesis of new ferulic/lipoic/comenic acid-melatonin hybrids as antioxidants and Nrf2 activators via Ugi reactionPachón-Angona, I.; Martin, H.; Chhor, S.; Oset-Gasque, M. J.; Refouvelet, B.; Marco-Contelles, José ; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2019Synthesis, antioxidant and Aβ anti-aggregation properties of new ferulic, caffeic and lipoic acid derivatives obtained by the Ugi four-component reactionBenchekroun, M.; Pachón-Angona, I.; Luzet, V.; Martin, H.; Oset-Gasque, M. J.; Marco-Contelles, José ; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2016Synthesis, regioselectivity, and DFT analysis of new antioxidant pyrazolo[4,3-c]quinoline-3,4-dionesTomassoli, I.; Herlem, G.; Picaud, F.; Benchekroun, M.; Bautista-Aguilera, Óscar M.; Luzet, V.; Jimeno, M. Luisa; Gharbi, T.; Refouvelet, B.; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2017Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapyDgachi, Y.; Sokolov, O.; Luzet, V.; Godyn, J.; Panek, D.; Bonet, A.; Martin, H.; Iriepa, I.; Moraleda, I.; García-Iriepa, C.; Janockova, J.; Richert, L.; Soukup, O.; Malawska, B.; Chabchoub, F.; Marco-Contelles, José ; Ismaili, L.artículo
closedAccessaccesoRestringido.pdf.jpg2016The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 ActivatorsBenchekroun, M.; Romero, A. ; Egea, Javier; León, Rafael; Michalska, P.; Buendía, I.; Jimeno, M. Luisa ; Jun, D.; Janockova, J.; Sepsova, V.; Soukup, O.; Bautista-Aguilera, Óscar M.; Refouvelet, B.; Ouari, O.; Marco-Contelles, José ; Ismaili, L.artículo